People

Emanuele Gabellieri

Emanuele Gabellieri leads medicinal chemistry at Booster Therapeutics, serving since2020 according to the grantor’s own researcher profile. He earned a pharmaceutical chemistryPhD from theUniversityofSiena and began atSienaBiotech in2007, developingBACE1inhibitors. Following organicprocesschemistry work, he joinedACImmune in2013, contributing toTauPET diagnosticPI-2620 andTauaggregation inhibitorACI-3024 discovery. From2019he led neuroinflammatory NLRP3research. Externalprogram clinical phases andregulatorymentions are historicalcareercontext fromthepublishedprofile, not approvalorclinicalbenefit ofBooster’s ownproteasomecandidates.